NCT00520286View on ClinicalTrials.gov

Phase 2, Multi-Center Trial of Modafinil for Methamphetamine Dependence

PHASE2CompletedINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

December 31, 2009

Study Completion Date

March 31, 2010

Conditions
Methamphetamine Dependence
Interventions
DRUG

Modafinil

200 mg or 400 mg /daily

DRUG

Placebo

Placebo / daily

Trial Locations (8)

50316

Powell Chemical Dependency Center, Des Moines

64131

START Research and Treatment, Kansas City

80220

University of Colorado Health Sciences Center, Denver

84148

Salt Lake City VA Medical Center, Salt Lake City

90502

Torrance Site, Torrance

91356

Matrix Institute on Addictions, Tarzana

92105

South Bay Treatment Center, San Diego

96813

John A. Burns School of Medicine, Honolulu

All Listed Sponsors
collaborator

VA Office of Research and Development

FED

lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00520286 - Phase 2, Multi-Center Trial of Modafinil for Methamphetamine Dependence | Biotech Hunter | Biotech Hunter